Pay in 4 interest-free payments of $5.63 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
In placebo controlled trials, pruritus was reported in 0-8% of patients receiving Niaspan compared to 2% of patients taking placebo
Why Metabolic Safety Matters Full-length human growth hormone therapy carries well-documented metabolic risks including IGF-1 elevation, impaired glucose tolerance, and increased diabetes risk
Consistent with these findings, a separate study reported that women, irrespective of diagnosis, showed lower ratios of KYNA to 3-HK and QA than men, with these differences further amplified by oral contraceptive use [53]
iScience 19, 461473
US$ 23.07
US$ 28.92
US$ 20.68
US$ 20.32
US$ 23.76
